Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Locoregional Recurrence × Fulvestrant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 117 Neoplasm Metastasis 16 Ovarian Neoplasms 7 Prostatic Neoplasms 5 Advanced Breast Cancer 5 Neoplasms 4 Breast Cancer Metastatic 4 Pancreatic Neoplasms 2 Lung Neoplasms 2 HER2-positive Breast Cancer 2 Estrogen Receptor-positive Breast Cancer 2 Endometrial Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Lobular 2 Breast Neoplasms, Male 2 The Neoadjuvant Therapy 1 Solid Tumor 1 Sex Cord-Gonadal Stromal Tumors 1 Sarcoma, Endometrial Stromal 1 Sarcoma 1 Salivary Gland Neoplasms 1 Neoplastic Cells, Circulating 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Malignant Neoplasms of Female Genital Organs 1 Locoregional Recurrence 1 Hyperglycemia 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Hormone Receptor Positive Breast Carcinoma 1

Interventions

ribociclib 1 exemestane 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05467891 2026-02-27

RaPhLRR

Hoosier Cancer Research Network

Phase 2 Recruiting

Locoregional Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡